» Articles » PMID: 38265879

Neutrophils in Physiology and Pathology

Overview
Journal Annu Rev Pathol
Publisher Annual Reviews
Specialty Pathology
Date 2024 Jan 24
PMID 38265879
Authors
Affiliations
Soon will be listed here.
Abstract

Infections, cardiovascular disease, and cancer are major causes of disease and death worldwide. Neutrophils are inescapably associated with each of these health concerns, by either protecting from, instigating, or aggravating their impact on the host. However, each of these disorders has a very different etiology, and understanding how neutrophils contribute to each of them requires understanding the intricacies of this immune cell type, including their immune and nonimmune contributions to physiology and pathology. Here, we review some of these intricacies, from basic concepts in neutrophil biology, such as their production and acquisition of functional diversity, to the variety of mechanisms by which they contribute to preventing or aggravating infections, cardiovascular events, and cancer. We also review poorly explored aspects of how neutrophils promote health by favoring tissue repair and discuss how discoveries about their basic biology inform the development of new therapeutic strategies.

Citing Articles

The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases.

Zeng L, Xiang W, Xiao W, Wu Y, Sun L MedComm (2020). 2025; 6(3):e70101.

PMID: 40060194 PMC: 11885892. DOI: 10.1002/mco2.70101.


Secondary Neutropenias.

Ward A Biomedicines. 2025; 13(2).

PMID: 40002910 PMC: 11853056. DOI: 10.3390/biomedicines13020497.


[Research Progress of Tumor-associated Neutrophils 
in the Occurrence and Development of Lung Cancer].

Li X, Zhou J, Zhao C, Zhang Y Zhongguo Fei Ai Za Zhi. 2025; 28(1):55-62.

PMID: 39988440 PMC: 11848648. DOI: 10.3779/j.issn.1009-3419.2025.101.02.


Bibliometric analysis of neutrophil extracellular traps induced by protozoan and helminth parasites (2008-2024).

Munoz-Caro T, Saraiva E, Mariante R Front Immunol. 2025; 16:1498453.

PMID: 39925815 PMC: 11802541. DOI: 10.3389/fimmu.2025.1498453.


Inhibiting CFTR through inh-172 in primary neutrophils reveals CFTR-specific functional defects.

Da Silva Cunha A, Blanter M, Renders J, Gouwy M, Lorent N, Boon M Sci Rep. 2024; 14(1):31237.

PMID: 39732786 PMC: 11682091. DOI: 10.1038/s41598-024-82535-z.


References
1.
Levental K, Yu H, Kass L, Lakins J, Egeblad M, Erler J . Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009; 139(5):891-906. PMC: 2788004. DOI: 10.1016/j.cell.2009.10.027. View

2.
Moss R, Mistry S, Konstan M, Pilewski J, Kerem E, Tal-Singer R . Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis. J Cyst Fibros. 2012; 12(3):241-8. DOI: 10.1016/j.jcf.2012.08.016. View

3.
Albrengues J, Shields M, Ng D, Park C, Ambrico A, Poindexter M . Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018; 361(6409). PMC: 6777850. DOI: 10.1126/science.aao4227. View

4.
Veglia F, Tyurin V, Blasi M, De Leo A, Kossenkov A, Donthireddy L . Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature. 2019; 569(7754):73-78. PMC: 6557120. DOI: 10.1038/s41586-019-1118-2. View

5.
Cao X, Hu Y, Luo S, Wang Y, Gong T, Sun X . Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma. Acta Pharm Sin B. 2019; 9(3):575-589. PMC: 6543032. DOI: 10.1016/j.apsb.2018.12.009. View